674 related articles for article (PubMed ID: 28985502)
1. The Revolution Continues: Newly Discovered Systems Expand the CRISPR-Cas Toolkit.
Murugan K; Babu K; Sundaresan R; Rajan R; Sashital DG
Mol Cell; 2017 Oct; 68(1):15-25. PubMed ID: 28985502
[TBL] [Abstract][Full Text] [Related]
2. Inhibition Mechanism of an Anti-CRISPR Suppressor AcrIIA4 Targeting SpyCas9.
Yang H; Patel DJ
Mol Cell; 2017 Jul; 67(1):117-127.e5. PubMed ID: 28602637
[TBL] [Abstract][Full Text] [Related]
3. Structural Basis for Guide RNA Processing and Seed-Dependent DNA Targeting by CRISPR-Cas12a.
Swarts DC; van der Oost J; Jinek M
Mol Cell; 2017 Apr; 66(2):221-233.e4. PubMed ID: 28431230
[TBL] [Abstract][Full Text] [Related]
4. The Anti-CRISPR Story: A Battle for Survival.
Maxwell KL
Mol Cell; 2017 Oct; 68(1):8-14. PubMed ID: 28985512
[TBL] [Abstract][Full Text] [Related]
5. Advances in Industrial Biotechnology Using CRISPR-Cas Systems.
Donohoue PD; Barrangou R; May AP
Trends Biotechnol; 2018 Feb; 36(2):134-146. PubMed ID: 28778606
[TBL] [Abstract][Full Text] [Related]
6. CRISPR-Based Technologies: Impact of RNA-Targeting Systems.
Terns MP
Mol Cell; 2018 Nov; 72(3):404-412. PubMed ID: 30388409
[TBL] [Abstract][Full Text] [Related]
7. CRISPR/Cas9 in Genome Editing and Beyond.
Wang H; La Russa M; Qi LS
Annu Rev Biochem; 2016 Jun; 85():227-64. PubMed ID: 27145843
[TBL] [Abstract][Full Text] [Related]
8. Real-time observation of DNA target interrogation and product release by the RNA-guided endonuclease CRISPR Cpf1 (Cas12a).
Singh D; Mallon J; Poddar A; Wang Y; Tippana R; Yang O; Bailey S; Ha T
Proc Natl Acad Sci U S A; 2018 May; 115(21):5444-5449. PubMed ID: 29735714
[TBL] [Abstract][Full Text] [Related]
9. [CRISPR/CAS9, the King of Genome Editing Tools].
Bannikov AV; Lavrov AV
Mol Biol (Mosk); 2017; 51(4):582-594. PubMed ID: 28900076
[TBL] [Abstract][Full Text] [Related]
10. Probing the structural dynamics of the CRISPR-Cas9 RNA-guided DNA-cleavage system by coarse-grained modeling.
Zheng W
Proteins; 2017 Feb; 85(2):342-353. PubMed ID: 27936513
[TBL] [Abstract][Full Text] [Related]
11. CRISPR-Cas guides the future of genetic engineering.
Knott GJ; Doudna JA
Science; 2018 Aug; 361(6405):866-869. PubMed ID: 30166482
[TBL] [Abstract][Full Text] [Related]
12. The discovery and development of the CRISPR system in applications in genome manipulation.
Lau V; Davie JR
Biochem Cell Biol; 2017 Apr; 95(2):203-210. PubMed ID: 28103055
[TBL] [Abstract][Full Text] [Related]
13. The next generation of CRISPR-Cas technologies and applications.
Pickar-Oliver A; Gersbach CA
Nat Rev Mol Cell Biol; 2019 Aug; 20(8):490-507. PubMed ID: 31147612
[TBL] [Abstract][Full Text] [Related]
14. CRISPR Mediated Genome Engineering and its Application in Industry.
Kaboli S; Babazada H
Curr Issues Mol Biol; 2018; 26():81-92. PubMed ID: 28879858
[TBL] [Abstract][Full Text] [Related]
15. Optimization of genome editing through CRISPR-Cas9 engineering.
Zhang JH; Adikaram P; Pandey M; Genis A; Simonds WF
Bioengineered; 2016 Apr; 7(3):166-74. PubMed ID: 27340770
[TBL] [Abstract][Full Text] [Related]
16. Precision genome editing in the CRISPR era.
Salsman J; Dellaire G
Biochem Cell Biol; 2017 Apr; 95(2):187-201. PubMed ID: 28177771
[TBL] [Abstract][Full Text] [Related]
17. Type III CRISPR-Cas System: Introduction And Its Application for Genetic Manipulations.
Liu T; Pan S; Li Y; Peng N; She Q
Curr Issues Mol Biol; 2018; 26():1-14. PubMed ID: 28879852
[TBL] [Abstract][Full Text] [Related]
18. Controlling and enhancing CRISPR systems.
Shivram H; Cress BF; Knott GJ; Doudna JA
Nat Chem Biol; 2021 Jan; 17(1):10-19. PubMed ID: 33328654
[TBL] [Abstract][Full Text] [Related]
19. Fanzor is a eukaryotic programmable RNA-guided endonuclease.
Saito M; Xu P; Faure G; Maguire S; Kannan S; Altae-Tran H; Vo S; Desimone A; Macrae RK; Zhang F
Nature; 2023 Aug; 620(7974):660-668. PubMed ID: 37380027
[TBL] [Abstract][Full Text] [Related]
20. Shooting the messenger: RNA-targetting CRISPR-Cas systems.
Zhu Y; Klompe SE; Vlot M; van der Oost J; Staals RHJ
Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29748239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]